Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Combe

Showing results (71-80 of 282) with videos related to

Pageof 29
Sort By:
Arthritis Care & Research|October 19, 2011
Nonsteroidal antiinflammatory drug intake according to the Assessment of SpondyloArthritis International Society Score in clinical trials evaluating tumor necrosis factor blockers: example of etanercept in advanced ankylosing spondylitisMaxime Dougados, Jurgen Braun, Sandor Szanto, et al.
Rheumatology (Oxford, England)|June 2, 2012
Continuous efficacy of etanercept in severe and advanced ankylosing spondylitis: results from a 12-week open-label extension of the SPINE studyMaxime Dougados, Jurgen Braun, Sandor Szanto, et al.
The Journal of Rheumatology|May 3, 2016
Comparison of Etanercept Monotherapy and Combination Therapy with Methotrexate in Psoriatic Arthritis: Results from 2 Clinical TrialsBernard Combe, Frank Behrens, Neil McHugh, et al.
The Journal of Rheumatology|July 4, 2012
Etanercept concentration in patients with rheumatoid arthritis and its potential influence on treatment decisions: a pilot studyClaire Immediato Daïen, Vincent Daïen, Ermis Parussini, et al.
Frontiers in Immunology|May 19, 2018
IL-10 Producing B Cells Ability to Induce Regulatory T Cells Is Maintained in Rheumatoid ArthritisJulie Mielle, Rachel Audo, Michael Hahne, et al.
RMD Open|September 17, 2024
Persistence of power Doppler ultrasonography-detected synovitis over 1 year of follow-up predicts poor prognosis in rheumatoid arthritis in clinical remission: the SONORE prospective longitudinal studyGael Mouterde, Cédric Lukas, Nathalie Filippi, et al.
Arthritis Research & Therapy|July 25, 2009
Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohortJacques-Eric Gottenberg, Corinne Miceli-Richard, Béatrice Ducot, et al.
Annals of the Rheumatic Diseases|February 19, 2017
Seven-year tolerability profile of glucocorticoids use in early rheumatoid arthritis: data from the ESPOIR cohortCamille Roubille, Nathalie Rincheval, Maxime Dougados, et al.
Rheumatology (Oxford, England)|July 16, 2015
The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohortJosefina Durán, Bernard Combe, Jingbo Niu, et al.
Annals of the Rheumatic Diseases|January 24, 2012
Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysisClaire Immediato Daïen, Yohan Duny, Thomas Barnetche, et al.
Pageof 29

Showing results (71-80 of 282) with videos related to

Sort By:
Pageof 29
Arthritis Care & Research|October 19, 2011
Nonsteroidal antiinflammatory drug intake according to the Assessment of SpondyloArthritis International Society Score in clinical trials evaluating tumor necrosis factor blockers: example of etanercept in advanced ankylosing spondylitisMaxime Dougados, Jurgen Braun, Sandor Szanto, et al.
Rheumatology (Oxford, England)|June 2, 2012
Continuous efficacy of etanercept in severe and advanced ankylosing spondylitis: results from a 12-week open-label extension of the SPINE studyMaxime Dougados, Jurgen Braun, Sandor Szanto, et al.
The Journal of Rheumatology|May 3, 2016
Comparison of Etanercept Monotherapy and Combination Therapy with Methotrexate in Psoriatic Arthritis: Results from 2 Clinical TrialsBernard Combe, Frank Behrens, Neil McHugh, et al.
The Journal of Rheumatology|July 4, 2012
Etanercept concentration in patients with rheumatoid arthritis and its potential influence on treatment decisions: a pilot studyClaire Immediato Daïen, Vincent Daïen, Ermis Parussini, et al.
Frontiers in Immunology|May 19, 2018
IL-10 Producing B Cells Ability to Induce Regulatory T Cells Is Maintained in Rheumatoid ArthritisJulie Mielle, Rachel Audo, Michael Hahne, et al.
RMD Open|September 17, 2024
Persistence of power Doppler ultrasonography-detected synovitis over 1 year of follow-up predicts poor prognosis in rheumatoid arthritis in clinical remission: the SONORE prospective longitudinal studyGael Mouterde, Cédric Lukas, Nathalie Filippi, et al.
Arthritis Research & Therapy|July 25, 2009
Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohortJacques-Eric Gottenberg, Corinne Miceli-Richard, Béatrice Ducot, et al.
Annals of the Rheumatic Diseases|February 19, 2017
Seven-year tolerability profile of glucocorticoids use in early rheumatoid arthritis: data from the ESPOIR cohortCamille Roubille, Nathalie Rincheval, Maxime Dougados, et al.
Rheumatology (Oxford, England)|July 16, 2015
The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohortJosefina Durán, Bernard Combe, Jingbo Niu, et al.
Annals of the Rheumatic Diseases|January 24, 2012
Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysisClaire Immediato Daïen, Yohan Duny, Thomas Barnetche, et al.
Pageof 29